I n 1876 Eli Lilly, a veteran of the civil war, founded a company in Indianapolis to bring scientific rigour to a medicines ...

SpaceX recently completed a record IPO.

With a share price of $1,182, Eli Lilly (LLY) is positioned for about 76% potential growth over the next three years in a ...

Wall Street is getting more bullish on the pharma giant's shares.

Eli Lilly and Company’s LLY stock has risen 18% in a month, driven mainly by a stellar third-quarter performance. Also, earlier this month, President Trump announced deals with Lilly and rival Novo ...

Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors.

Eli Lilly and Company remains a Buy, supported by robust incretin-driven growth and strategic expansion in obesity treatments. LLY pivots from scarcity to access economics, prioritizing volume over ...

Shares of Eli Lilly have risen by over 40% since the company last reported earnings.

Eli Lilly's GLP-1 drug portfolio should power the business for at least the next decade. But the market appears well aware of the company's weight loss drug success. Weight loss drugs are set to ...

In the latest China pharmaceutical industry collaboration pact with a global drug leader, Abbisko said today it will work ...

In 1876, Colonel Eli Lilly opened a small pharmaceutical company in Indianapolis with an idea that was, at the time, radical to some: make medicine that actually worked. He had witnessed soldiers die ...